Navigation Links
Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting

CAMBRIDGE, Mass., April 18, 2007 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases, announced today that 11 abstracts have been accepted for presentation at the 2007 Digestive Disease Week (DDW) meeting, to be held in Washington D.C. from May 19 to 24. The abstract contents are available on the DDW web site at http://www.ddw.org .

Hepatitis C Abstracts:

Dr. Norman Gitlin, Professor of Medicine, Atlanta Gastroenterology Associations and Emory University, Atlanta, GA, will present "Valopicitabine (NM283) Plus Peg-Interferon Alfa-2a (peg-IFN) in Treatment-Naive Patients With HCV-1 Infection: Preliminary Results At Weeks 24 and 48" in a poster session beginning on Monday, May 21, 2007 at 8:00 a.m. Eastern Daylight Time (EDT).

Dr. Maribel Rodriguez-Torres, President, Fundacion de Investigacion de Diego, Santurce, Puerto Rico, will present "Final Results from a Phase IIA Pharmacokinetic Study of Valopicitabine (NM283) and Peg-IFNa-2b in Patients with Genotype 1 Chronic Hepatitis C" in a poster session beginning on Monday, May 21, 2007 at 8:00 a.m. EDT.

About Valopicitabine (NM283)

Valopicitabine is an investigational HCV RNA polymerase inhibitor being evaluated in ongoing clinical trials for the treatment of hepatitis C.

Hepatitis B Abstracts

Dr. Maria Seifer, Director, Biology at Idenix Pharmaceuticals, will present "Genotypic Analysis of Patients with Evaluable HBV DNA After 1 Year of Telbivudine Therapy in the GLOBE Registration Trial" in a meeting session on Sunday, May 20, 2007 at 11:15 a.m. EDT.

Dr. Steven Han, Associate Clinical Professor in the Division of Digestive Diseases and the Division of Liver and Pancreas Transplantation and Directo
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:8/27/2015)... Calif. , Aug. 27, 2015 DURECT ... is scheduled to present at three upcoming healthcare conferences.  ... President and CEO, will present at the Rodman & ... a.m. Eastern time. The conference is being held at ... City . A live audio webcast of the ...
(Date:8/27/2015)... 27, 2015  Eli Lilly and Company (NYSE: ... Conference on Thursday, September 17, 2015. Sue Mahony ... Oncology and Richard Gaynor , M.D., senior vice ... Oncology, will participate in a fireside chat at 3:30 ... audio webcast will be available on the "Webcasts & ...
(Date:8/27/2015)... Ga. , Aug. 27, 2015  MiMedx Group, ... medicine company utilizing human amniotic tissue and patent-protected ... therapies for the Wound Care, Surgical, Orthopedic, Spine, ... responded today and corrected the multiple inaccuracies in ... Foundation ("MTF") regarding the recent rulings from the ...
Breaking Medicine Technology:DURECT to Participate in Upcoming Healthcare Conferences 2Lilly to Participate in Morgan Stanley Global Healthcare Conference 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4
(Date:8/29/2015)... ... ... The popular television program VOICES IN AMERICA, hosted by legendary star of ... an entire short segment to the subject of diabetes. Diabetes is a debilitating health ... basis, but recent advancements in medical science may prove to be a significant breakthrough ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 ... Zoo to celebrate children helping children, a thank you to the many creative ... have contributed to the United Methodist initiative to end malaria deaths. , The ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Position and Best Practices for Compliance, **Presented by FDAnews and GessNet**, Oct. ... by internationally renowned expert Fubin Wu, has been specifically designed to provide ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, ... protein with zero fat, carbs, sugar, gluten, lactose or caffeine in a convenient ... the 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) ...
(Date:8/28/2015)... ... 2015 , ... The Nashville Business Journal recently announced its ... Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one of ... Awards will recognize Nashville military veterans who, through their professional and personal efforts, ...
Breaking Medicine News(10 mins):Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2
... critics say , , WEDNESDAY, April 30 (HealthDay News) -- ... in the United States is in a state of ... food safety system include out-of-date laws, poor use of ... to the report Fixing Food Safety: Protecting America,s ...
... a significantly higher risk of developing Alzheimers disease ... unexplained. Now, researchers at the Salk Institute for ... the diabetes Alzheimers interaction. , In a ... Neurobiology of Aging, investigators led by David R. ...
... cells were coaxed into becoming three kinds of cardiac ... cardiac cells have been created from mouse skin cells ... embryonic stem cells, say researchers at the University of ... study to show that induced pluripotent stem (iPS) cells, ...
... to See How Drugs Actually Work in Real ... ... iGuard.org, a free,patient-driven online healthcare community, announced the launch of an,innovative new ... all Americans taking prescription drugs, and eight out of,ten surfing the web ...
... National Walk @ Lunch Day(SM) encourages healthier lifestyles, ... Blue,Shield companies nationwide are working with employers of ... toward healthier lifestyles. Citing the,tremendous cost that inactive ... healthcare bill, Blue Cross and Blue Shield companies,are ...
... HI ) today announced that its Board of Directors ... of $0.1825 per share,on the company,s common stock. The ... at the close of business on June 16, 2008., ... inaugural dividend is based,on the strength of our fundamentals, ...
Cached Medicine News:Health News:Report Slams U.S. Food Safety System 2Health News:Report Slams U.S. Food Safety System 3Health News:Report Slams U.S. Food Safety System 4Health News:Salk study links diabetes and Alzheimer's disease 2Health News:Salk study links diabetes and Alzheimer's disease 3Health News:Mouse Skin Cells Reprogrammed to Act Like Embryonic Stem Cells 2Health News:iGuard.org Alters the Face of E-Health: New Web Service Draws 10,000 New Patients Weekly 2Health News:iGuard.org Alters the Face of E-Health: New Web Service Draws 10,000 New Patients Weekly 3Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 2Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 3Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 4Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 5Health News:Hillenbrand, Inc. Declares First Quarterly Dividend As a New Publicly Traded Company 2
... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...
... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...
... hand-held, point-of-care device for the qualitative detection of ... The TOX/See device can detect up to nine ... to 8 minutes and requires only a few ... packaged to maximize convenience and ease of use. ...
... is a 1-step, hand-held, point-of-care device for the ... human urine. The TOX/See device can detect ... drugs in 3 to 8 minutes and requires ... cassette is individually packaged to maximize convenience and ...
Medicine Products: